Nalaganje...

Update of research on the role of EZH2 in cancer progression

Accumulating evidence shows that enhancer of zeste homolog 2 (E2H2) is upregulated in a broad range of cancer types, such as breast cancer, prostate cancer, ovarian cancer, and colon cancer. Therefore, inhibiting EZH2 expression may be a promising strategy for anticancer therapy. This review focuses...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Shen, Liang, Cui, Jing, Liang, Shumei, Pang, Yingxin, Liu, Peishu
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3622432/
https://ncbi.nlm.nih.gov/pubmed/23589697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S42453
Oznake: Označite
Brez oznak, prvi označite!